Mannkind (MNKD) Stock Price
$6.14 0.5%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
7 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Mannkind, AI stock picks, stock alerts and much more.
MNKD AI Stock Analysis
AI stock analysis for MNKD is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Mannkind (MNKD) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Mannkind (MNKD) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Mannkind (MNKD), currently trading at $6.14, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About MNKD
-
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States.
-
Symbol
MNKD
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
1.7B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$23.91 4.7% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.15 1.8% |
4 |
 |
Moderna MRNA |
$43.59 3% |
4 |
 |
Anavex Life Sciences AVXL |
$9.73 1.8% |
6 |
 |
BridgeBio Pharma BBIO |
$36.32 0% |
7 |
News
MNKD Alternative Data
Web Traffic
Mannkind receives an estimated 20262 monthly visitors to mannkindcorp.com.
-
Web Traffic
20262
-
Change from Previous Month
7.8%
-
3 Month Change
41.2%
-
YoY Change
41.2%
News Mentions
Mannkind was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
Mannkind has 2,762 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.5% over the last month.
-
Twitter Followers
2762
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
1.6%
-
YoY Change
1.6%
Facebook Engagement
Mannkind has engaged 48 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
48
-
Daily Change
23.8%
-
1 Month Change
0%
-
3 Month Change
1500%
-
YoY Change
1500%
Youtube Subscribers
Mannkind has 270 subscribers on its main Youtube channel.
-
Youtube Subscribers
270
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0.7%
-
YoY Change
0.7%
LinkedIn Followers
13,571 are following Mannkind on LinkedIn, up by 2.4% over the last month.
-
LinkedIn Followers
13571
-
Daily Change
0.1%
-
1 Month Change
2.4%
-
3 Month Change
5.5%
Job Postings
Mannkind currenly has an estimated 24 open job postings, up by 33.3% over the last month.
-
Job Postings
24
-
Daily Change
4.3%
-
1 Month Change
33.3%
-
3 Month Change
71.4%
-
YoY Change
71.4%
LinkedIn Employees
According to LinkedIn, Mannkind has 557 employees, up by 0.2% over the last month.
-
LinkedIn Employees
557
-
Daily Change
0%
-
1 Month Change
0.2%
-
3 Month Change
0.4%
-
YoY Change
0.4%
Instagram Followers
Mannkind has 1,116 Instagram Followers on its main Instagram account, up by 0.8% over the last month.
-
Instagram Followers
1116
-
Daily Change
0%
-
1 Month Change
0.8%
-
3 Month Change
1.9%
-
YoY Change
1.9%
Business Outlook
-
Business Outlook
82
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
MNKD Financials
MNKD Key Metrics
-
Total Revenue
$70.1M
-
Net Income
$11.6M
-
Earnings per Share
$0.042
-
Free cash flow
$7.9M
-
EBITDA
$12.8M
-
EBITDA Ratio
0.18208
-
Total Assets
$464.2M
MNKD 2-year Revenue & Income
MNKD 2-year Free Cash Flow
MNKD Technicals
MNKD SMA
MNKD RSI
FAQ
What's the current price of Mannkind (MNKD) Stock?
The price of an Mannkind (MNKD) share is $6.14.
What's the market cap of Mannkind?
The current market cap of Mannkind is 1.7B.
Should I buy or sell MNKD?
Mannkind shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Mannkind is better viewed as a hold or accumulate position while waiting for further developments.
Is Mannkind a good investment?
The current analysis of Mannkind's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Mannkind's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Mannkind (MNKD) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Mannkind stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Mannkind (MNKD) that investors often compare it to?
Mannkind (MNKD) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Mannkind's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Mannkind's stock price to be around $6.49 in 2026. Starting from the current price of $6.14, this represents a 5.7% change in price, indicating a bullish outlook for the stock.
How to buy Mannkind (MNKD) Stock?
Mannkind stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Mannkind shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.